I Castagna1, A M Roszkowska2,3, F Alessandrello1, G W Oliverio1, G Tumminello1, R Gallizzi4, G Conti5, P Aragona1. 1. Ophthalmology Unit, Department of Biomedical Sciences, University Hospital of Messina, Messina, Italy. 2. Ophthalmology Section, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Kraków University, Kraków, Poland. aroszkowska@unime.it. 3. A.O.U. Policlinico G. Martino Messina, Via Consolare Valeria 1, 98125, Messina, Italy. aroszkowska@unime.it. 4. Unit of Pediatrics, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy. 5. Pediatric Nephrology and Rheumatology Unit, University Hospital of Messina, Messina, Italy.
Abstract
PURPOSE: To investigate the clinical and laboratory characteristics of the children affected by juvenile idiopathic arthritis (JIA) who developed uveitis. METHODS: In this retrospective study, we have examined data of 109 patients aged from 3 to 16 years, affected by JIA and followed at Paediatrics Rheumatology Clinic and Ophthalmology Clinic of University Hospital of Messina in the period from 2007 to 2017. The main outcome measures were clinical and laboratory findings related to JIA and ocular involvement. The prevalence of ocular signs and symptoms was determined and correlated with age. RESULTS: Twenty-one (19.3%) subjects developed uveitis. Two different peaks of age with ocular involvement were registered. The first occurred between 4 and 6 years and the second between 10 and 12 years. All subjects in the first group resulted to be female, presented oligoarticular arthritis and chronic anterior uveitis. In the second group, the 84% of patients were male with different types of JIA and acute anterior uveitis. The prevalence of ocular complications was higher in the first group. CONCLUSIONS: Two peaks of age emerged and were characterized by different clinical outcomes of arthritis and ocular involvement. The first occurred between 4 and 6 years and interested females affected by oligoarticular JIA who develop chronic anterior uveitis. The second appeared at 10-12 years and interested older males affected by different types of JIA with acute anterior uveitis. Early diagnosis and cooperation between paediatric rheumatologist and ophthalmologist are of great importance in the proper management of JIA children with uveitis.
PURPOSE: To investigate the clinical and laboratory characteristics of the children affected by juvenile idiopathic arthritis (JIA) who developed uveitis. METHODS: In this retrospective study, we have examined data of 109 patients aged from 3 to 16 years, affected by JIA and followed at Paediatrics Rheumatology Clinic and Ophthalmology Clinic of University Hospital of Messina in the period from 2007 to 2017. The main outcome measures were clinical and laboratory findings related to JIA and ocular involvement. The prevalence of ocular signs and symptoms was determined and correlated with age. RESULTS: Twenty-one (19.3%) subjects developed uveitis. Two different peaks of age with ocular involvement were registered. The first occurred between 4 and 6 years and the second between 10 and 12 years. All subjects in the first group resulted to be female, presented oligoarticular arthritis and chronic anterior uveitis. In the second group, the 84% of patients were male with different types of JIA and acute anterior uveitis. The prevalence of ocular complications was higher in the first group. CONCLUSIONS: Two peaks of age emerged and were characterized by different clinical outcomes of arthritis and ocular involvement. The first occurred between 4 and 6 years and interested females affected by oligoarticular JIA who develop chronic anterior uveitis. The second appeared at 10-12 years and interested older males affected by different types of JIA with acute anterior uveitis. Early diagnosis and cooperation between paediatric rheumatologist and ophthalmologist are of great importance in the proper management of JIAchildren with uveitis.
Authors: Arnd Heiligenhaus; Ivan Foeldvari; Clive Edelsten; Justine R Smith; Rotraud K Saurenmann; Bahram Bodaghi; Joke de Boer; Elizabeth Graham; Jordi Anton; Kaisu Kotaniemi; Friederike Mackensen; Kirsten Minden; Susan Nielsen; Egla C Rabinovich; Athimalaipet V Ramanan; Vibeke Strand Journal: Arthritis Care Res (Hoboken) Date: 2012-09 Impact factor: 4.794
Authors: Rosa Bou; Alfredo Adán; Fátima Borrás; Beatriz Bravo; Inmaculada Calvo; Jaime De Inocencio; Jesús Díaz; Julia Escudero; Alex Fonollosa; Carmen García de Vicuña; Victoria Hernández; Rosa Merino; Jesús Peralta; María-Jesús Rúa; Pilar Tejada; Jordi Antón Journal: Rheumatol Int Date: 2015-02-06 Impact factor: 2.631
Authors: Jennifer E Thorne; Fasika Woreta; Sanjay R Kedhar; James P Dunn; Douglas A Jabs Journal: Am J Ophthalmol Date: 2007-03-23 Impact factor: 5.258
Authors: E Del Giudice; C Simio; A Scala; A Di Coste; G La Torre; L Spadea; R Lubrano; M Duse; M P Paroli Journal: Int Ophthalmol Date: 2021-10-20 Impact factor: 2.031